Scott Ohanesian has held executive roles over the past 19 years for Clinical Logistics Organizations and Contract Manufacturing Organizations (CMOs), managing global logistics for Phase I through IV clinical trials.
He currently leads the QuickSTAT U.S. commercial operations team to build strategic relationships with pharmaceutical and biotech companies in order to provide comprehensive solutions for their global supply chain, ensuring product integrity and patient safety.
Prior to joining QuickSTAT, Scott managed the Asia Pacific commercial operations for Marken Limited, where he implemented the commercial strategy for the company in key markets, such as Australia, China, India, Japan, Singapore, South Korea, and Taiwan. Prior to that position, he was in a global strategic management role at a CMO, creating mutually beneficial partnership models.
He is trained and well versed in Good Manufacturing Practices, (GMP) and has helped create innovative logistics solutions for numerous new drug products--from formulation development through to commercialization, including cutting edge cell, gene, and CAR-T therapies.
Scott is a graduate of Boston College with a Bachelor of Science in Finance and a Masters of International Law in Diplomacy from The Fletcher School at Tufts University, with affiliated course work at Harvard Law School and Harvard Business School.
Scott co-leads the Cell and Gene Therapy Education Team for the Global Clinical Supplies Group.